Tech Company Financing Transactions

Concert Pharmaceuticals Funding Round

On 7/17/2006, Concert Pharmaceuticals raised $10 million in Series A funding from Skyline Ventures, Three Arch Partners and TVM Capital.

Transaction Overview

Announced On
7/17/2006
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors

Skyline Ventures (Lead Investor) (John Freund)

Three Arch Partners (Lead Investor) (Wilf Jaeger)

TVM Capital (Lead Investor) (Stephen Hoffman)

Greylock Partners

QVT Fund

Proceeds Purpose
We are very pleased to have gained the backing of these leading investors, which will enable Concert to rapidly deploy its proprietary technologies.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
99 Hayden Ave. 500
Lexington, MA 02421
USA
Email Address
Overview
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform to create novel small molecule drugs.
Profile
Concert Pharmaceuticals LinkedIn Company Profile
Social Media
Concert Pharmaceuticals Company Twitter Account
Company News
Concert Pharmaceuticals News
Facebook
Concert Pharmaceuticals on Facebook
YouTube
Concert Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Roger Tung
  Roger Tung LinkedIn Profile  Roger Tung Twitter Account  Roger Tung News  Roger Tung on Facebook
Chief Financial Officer
Marc Becker
  Marc Becker LinkedIn Profile  Marc Becker Twitter Account  Marc Becker News  Marc Becker on Facebook
Chief Operating Officer
Nancy Stuart
  Nancy Stuart LinkedIn Profile  Nancy Stuart Twitter Account  Nancy Stuart News  Nancy Stuart on Facebook
VP - Bus. Development
James Cassella
  James Cassella LinkedIn Profile  James Cassella Twitter Account  James Cassella News  James Cassella on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/15/2006: SeeControl venture capital transaction
Next: 7/17/2006: UnWired Buyer venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary